⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADCT News
ADC Therapeutics SA
Post-ASCO 2026 Insights: Trial Development and Execution Strategies, Upcoming Webinar Hosted by Xtalks
prnewswire.com
ADCT
Form 8-K
sec.gov
ADCT
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
prnewswire.com
ADCT
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire.com
ADCT
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL
ADC Therapeutics S.A. Investigated by the Portnoy Law Firm
globenewswire.com
ADCT
ADC Therapeutics Announces New Employee Inducement Grant
prnewswire.com
ADCT
Form 8-K
sec.gov
ADCT
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
prnewswire.com
ADCT
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire.com
ADCT